Cargando…

Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines

The safety and precision of peptide antigens has prompted the search for adjuvants capable of increasing the immune response against these intrinsically poorly immunogenic antigens. The integration of both immunostimulants and peptide antigens within nanometric delivery systems for their co-delivery...

Descripción completa

Detalles Bibliográficos
Autores principales: Correia-Pinto, Jorge F., Csaba, Noemi, Schiller, John T., Alonso, Maria J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586475/
https://www.ncbi.nlm.nih.gov/pubmed/26378586
http://dx.doi.org/10.3390/vaccines3030730
_version_ 1782392365986611200
author Correia-Pinto, Jorge F.
Csaba, Noemi
Schiller, John T.
Alonso, Maria J.
author_facet Correia-Pinto, Jorge F.
Csaba, Noemi
Schiller, John T.
Alonso, Maria J.
author_sort Correia-Pinto, Jorge F.
collection PubMed
description The safety and precision of peptide antigens has prompted the search for adjuvants capable of increasing the immune response against these intrinsically poorly immunogenic antigens. The integration of both immunostimulants and peptide antigens within nanometric delivery systems for their co-delivery to immune cells is a promising vaccination strategy. With this in mind, the potential synergistic effect of the immunostimulant poly (I:C) (pIC) and a T-Helper peptide (PADRE), integrated into a chitosan (CS) based nanostructure, was explored. The value of this nanostructured combination of materials was assessed for a peptide antigen (1338aa) derived from the HPV-16 L2 protein. These nanoparticles, produced by ionic gelation technique, exhibited a nanometric size (<300 nm), a high positive surface charge (>40 mV) and high pIC association efficiency (>96%). They also showed capacity for the association of both the 1338aa and PADRE peptides. The influence of the presence of pIC and PADRE in the nanocomposition, as well as that of the peptide presentation form (encapsulated versus surface adsorbed) on the antibody induction was evaluated in a preliminary in vivo study. The data obtained highlights the possibility to engineer nanoparticles through the rational combination of a number of adjuvant molecules together with the antigen.
format Online
Article
Text
id pubmed-4586475
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-45864752015-10-06 Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines Correia-Pinto, Jorge F. Csaba, Noemi Schiller, John T. Alonso, Maria J. Vaccines (Basel) Article The safety and precision of peptide antigens has prompted the search for adjuvants capable of increasing the immune response against these intrinsically poorly immunogenic antigens. The integration of both immunostimulants and peptide antigens within nanometric delivery systems for their co-delivery to immune cells is a promising vaccination strategy. With this in mind, the potential synergistic effect of the immunostimulant poly (I:C) (pIC) and a T-Helper peptide (PADRE), integrated into a chitosan (CS) based nanostructure, was explored. The value of this nanostructured combination of materials was assessed for a peptide antigen (1338aa) derived from the HPV-16 L2 protein. These nanoparticles, produced by ionic gelation technique, exhibited a nanometric size (<300 nm), a high positive surface charge (>40 mV) and high pIC association efficiency (>96%). They also showed capacity for the association of both the 1338aa and PADRE peptides. The influence of the presence of pIC and PADRE in the nanocomposition, as well as that of the peptide presentation form (encapsulated versus surface adsorbed) on the antibody induction was evaluated in a preliminary in vivo study. The data obtained highlights the possibility to engineer nanoparticles through the rational combination of a number of adjuvant molecules together with the antigen. MDPI 2015-09-11 /pmc/articles/PMC4586475/ /pubmed/26378586 http://dx.doi.org/10.3390/vaccines3030730 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Correia-Pinto, Jorge F.
Csaba, Noemi
Schiller, John T.
Alonso, Maria J.
Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines
title Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines
title_full Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines
title_fullStr Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines
title_full_unstemmed Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines
title_short Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines
title_sort chitosan-poly (i:c)-padre based nanoparticles as delivery vehicles for synthetic peptide vaccines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586475/
https://www.ncbi.nlm.nih.gov/pubmed/26378586
http://dx.doi.org/10.3390/vaccines3030730
work_keys_str_mv AT correiapintojorgef chitosanpolyicpadrebasednanoparticlesasdeliveryvehiclesforsyntheticpeptidevaccines
AT csabanoemi chitosanpolyicpadrebasednanoparticlesasdeliveryvehiclesforsyntheticpeptidevaccines
AT schillerjohnt chitosanpolyicpadrebasednanoparticlesasdeliveryvehiclesforsyntheticpeptidevaccines
AT alonsomariaj chitosanpolyicpadrebasednanoparticlesasdeliveryvehiclesforsyntheticpeptidevaccines